Juste-Dolz, Augusto
Teixeira, William
Pallás-Tamarit, Yeray
Carballido-Fernández, Mario
Carrascosa, Javier
Morán-Porcar, Ángela
Redón-Badenas, María Ángeles
Pla-Roses, María Gracia
Tirado-Balaguer, María Dolores
Remolar-Quintana, María José
Ortiz-Carrera, Jon
Ibañez-Echevarría, Ethel
Maquieira, Angel
Giménez-Romero, David
Funding for this research was provided by:
Generalitat Valenciana (DOGV no. 8815, May 19, 2020, pp. 16712–16726)
University of Valencia and INCLIVA|VLC Biomedical Research Institute (PI-2021-004)
Universitat de Valencia
Article History
Received: 7 March 2024
Revised: 7 June 2024
Accepted: 11 June 2024
First Online: 26 June 2024
Declarations
:
: All procedures strictly adhered to established guidelines and regulations. Ethical approvals were granted by the Biomedical Research Ethics Committee of the La Fe University and Polytechnic Hospital in Valencia, Spain, and the University General Hospital of Castellon, Spain. Additionally, the Health Centre at the Universitat Politècnica de València and the Fortuny nursing home in Valencia, Spain, permitted testing for their interns.
: Exhaled air samples were monitored on-site at several locations, including La Fe University and Polytechnic Hospital in Valencia, University General Hospital of Castellon, Health Centre at the Universitat Politècnica de València, and Fortuny nursing home in Valencia. Sampling occurred from February 2nd, 2021, to November 24th, 2021. A total of 33 patients were analyzed at the University General Hospital of Castellon, and 21 patients were analyzed at La Fe University and Polytechnic Hospital in Valencia, totaling 54 patients. Control subjects included 84 individuals from the UPV Health Centre “Juana Portaceli,” 25 from the Fortuny nursing home, 12 from La Fe Hospital, and 7 from the Hospital of Castellon, totaling 128. Special measures were taken to prevent the spread of the virus during sampling.
: The authors declare no competing interests.